SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Nebius Group NV is a technology company that provides infrastructure and services to AI builders worldwide. It offers Nebius AI, an AI-centric cloud platform provides full-stack infrastructure, including large-scale GPU clusters, cloud services, and developer tools. The company also operates through specialized brands: Toloka AI, which partners in data for generative AI development; TripleTen, an edtech platform focused on re-skilling individuals for tech careers; and Avride, which develops autonomous driving technology. Nebius Group was founded by Elena Kolmanovskaya, Ilya Segalovich, Mikhail Fadeev, and Arkady Volozh in 1989 and is headquartered in Amsterdam, the Netherlands.

Nebius Group N.V. - Ordinary Shares - Class A

Nebius Group N.V. 

Nebius Group is surging as investors react to strong earnings results that highlighted significant revenue growth and a positive shift to profitability, effectively countering bearish short-selling narratives. Community sentiment is overwhelmingly bullish, with active discussions focusing on the potential for a major short squeeze and the company's aggressive expansion plans in the AI cloud infrastructure sector.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, Peter Salanki, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeave is trending following a strong quarterly report that exceeded revenue expectations and highlighted an accelerating demand for AI infrastructure, fueled by a massive and growing backlog. While the company's robust forward guidance and expanded customer commitments have ignited bullish momentum, investors remain deeply divided, with many debating the sustainability of the company's heavy debt load and high capital expenditure relative to its current profitability.

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

Super Micro Computer is surging following a blockbuster earnings report that beat analyst expectations and featured robust FY27 revenue guidance, prompting the company to suspend its previously planned stock dilution program. Investors are actively discussing the stock's significant undervaluation relative to its massive order backlog and revenue growth, fueling intense speculation about a potential short squeeze as Wall Street analysts begin to revise their price targets upward.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

The SPY is currently trading in a tight, range-bound pattern as investors brace for the latest inflation data release, which many in the community anticipate will be heavily managed or "cooked" by government officials to appear in line with expectations. Despite ongoing geopolitical tensions and skepticism regarding economic health, traders are intensely focused on how this key data point will dictate the next move for interest rates and the broader market's ability to maintain its current levels.

Firefly Aerospace, Inc. engages in the design and manufacture of space launch vehicles. The company was founded by Thomas E. Markusic, Mark Watt, and Max Polyakov in January 2017 and is headquartered in Leander, TX.

Firefly Aerospace Inc.

Firefly Aerospace is seeing increased trader interest ahead of its upcoming earnings report, with the community actively debating whether the company's strong revenue growth and significant contract backlog will lead to a breakout. While investors remain cautious regarding sector-wide volatility and broader market headwinds, many are closely monitoring the stock's ability to maintain upward momentum as it builds out its launch and defense capabilities.

United States Antimony Corp. engages in the extraction, processing and sale of antimony, zeolite, silver, and gold products. It operates through the following segments: United States Antimony Operations, Mexican Antimony Operations, Precious Metals Recovery, and United States Zeolite Operations. The company was founded by John C. Lawrence in June 1968 and is headquartered in Dallas, TX.

United States Antimony Corp.

United States Antimony Corp is facing heightened volatility following a significant downward revision to its 2026 revenue guidance, attributed to lower market prices for antimony and delivery shifts. Despite the financial miss and resulting share price pressure, the community remains actively divided between investors frustrated by management's execution and those maintaining a bullish long-term thesis centered on the company's status as the only fully integrated domestic antimony producer.

Definium Therapeutics, Inc. operates as clinical stage biopharmaceutical company, which engages in developing novel product candidates to treat brain health disorders. The company was founded by Stephen L. Hurst, Scott M. Freeman, Leonard Latchman and Jamon Alexander Rahn on July 26, 2010 and is headquartered in New York, NY.

Definium Therapeutics Inc.

Definium Therapeutics is experiencing intense momentum as the community reacts to positive Phase 3 Voyage study results for its lead anxiety drug, with traders actively debating the stock's valuation, dilution impacts, and potential for further clinical breakthroughs. Investors are closely monitoring price action as the company shifts from a developmental asset toward potential commercial readiness, keeping the symbol trending due to its volatile mix of breakthrough clinical milestones and institutional-led equity offerings.

Velo3D, Inc. operates as a technology company, which engages in developing and manufacturing metal laser sintering printing machines for 3D printing. Its products include assure system, flow software, sapphire printer & sapphire XC. The company was founded by Benyamin Buller in June 2014 and is headquartered in Fremont, CA.

Velo3D Inc

Velo3D is experiencing heightened volatility and strong community interest driven by institutional growth projections and its strategic role in the aerospace and defense manufacturing sectors. Investors are actively debating the potential for a short squeeze as the stock navigates technical support levels following recent fluctuations.

Cava Group, Inc. is a holding company, which engages in the category-defining Mediterranean fast-casual restaurant brand, bringing together healthful food and bold, satisfying flavors at scale. It operates through the following segments: CAVA and CAVA Foods. The CAVA segment includes the operations of all company-owned CAVA restaurants. The CAVA Foods segment includes the production of dips and spreads used in CAVA restaurants as well as sales from the consumer-packaged goods (CPG) business. The company was founded by Brett Schulman, Ike Grigoropoulus, Dimitri Moshovitis, and Theodore Xenohristos in 2010 and is headquartered in Washington, DC.

Cava Group Inc

CAVA Group Inc

CAVA is trending as investor sentiment remains bullish following impressive Q2 earnings that showed strong same-store sales and robust traffic growth, effectively silencing Cyclospora-related concerns. While the stock has faced some valuation-based volatility and short-term profit-taking, the community remains divided between those who view it as a high-growth 'best of breed' long-term compounder and skeptics wary of its premium P/E multiple.

Lumentum Holdings, Inc. engages in the provision of optical and photonic products. It operates through the Cloud and Networking, and Industrial Tech segments. The Cloud and Networking segment refers to a portfolio of optical and photonic components, modules, and subsystems. The Industrial Tech segment includes solid-state lasers, kilowatt-class fiber lasers, ultrafast lasers, diode lasers, and gas lasers. The company was founded in 1979 and is headquartered in San Jose, CA.

Lumentum Holdings Inc

Lumentum Holdings is trending as investors react to a significant earnings beat and raised guidance that highlights accelerating AI-driven demand for optical connectivity. The community is actively debating the company's laser technology moat, while bullish sentiment is further bolstered by multiple analyst price target upgrades post-earnings.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

BNB Plus Corp. (BNBX) Announces Nasdaq Delisting Determination and Transition to OTCQB Market; Company to Seek Review by Nasdaq Listing and Hearing Review Council

BNB Plus Corp. (Nasdaq: BNBX) ("BNB Plus" or the "Company") today announced that it has received a delisting determination from the Hearing Panel of the Nasdaq Stock Market LLC ("Nasdaq") as a result of the Company's non-compliance with the minimum $1.00 bid price requirement set forth in Nasdaq...

12 Health Care Stocks Moving In Monday's After-Market Session

Gainers

Gain Therapeutics (NASDAQ:GANX) stock rose 20.2% to $2.38 during Monday's after-market session. The market value of their outstanding shares is at $74.6 million.
BNB Plus (NASDAQ:BNBX) stock rose 9.78% toread more...

BNB Plus Corp. (BNBX) Secures Initial Commitments for $4.1M in Strategic Financing

BNB Plus Corp. (Nasdaq: BNBX) ("BNB Plus" or the "Company"), today announced it has secured initial commitments for $4.1M of convertible preferred stock financing, with additional commitments anticipated to bring total proceeds to $5.0M (the "Financing"). Proceeds from the Financing will be used to...

BNB Plus Corp. Completes Historic $1.2 Million LineaDNA Order

BNB Plus Corp. (Nasdaq: BNBX) ('BNB Plus' or the 'Company'), today announced that its biopharmaceutical subsidiary, LineaRx, Inc. ('LineaRx'), has successfully completed production of its largest...

BNB Plus Corp. Announces Review of Strategic Alternatives to Maximize Shareholder Value

BNB Plus Corp. (Nasdaq: BNBX) ("BNB Plus" or the "Company"), a Nasdaq-listed digital asset treasury company focused on Binance's BNB token, today announced that its Board of Directors has authorized a formal review of strategic alternatives to maximize shareholder value and also provided an update...

Anthropic’s ‘Mythos’ Triggers Scramble Among Coinbase, Binance: Report

Equity

Large banks and tech organizations have early access to Mythos, while crypto companies still rely on older AI models and internal security technologies.

BNB Plus Corp. Announces European Patent Grant for Fundamental Technology Underlying its Linea IVT Platform

BNB Plus Corp. (Nasdaq: BNBX) ('BNBX' or the 'Company'), announced today that its biopharmaceutical subsidiary, LineaRx, Inc. ('LineaRx'), has been granted a European patent by the European Patent...

BNB Plus Corp. (BNBX) Receives Two New Orders for LineaDNA from Genetic Medicine Developers

BNB Plus Corp. (Nasdaq: BNBX) ('BNBX' or the 'Company') today announced that its biopharmaceutical subsidiary, LineaRx, Inc. ('LineaRx'), has received two new orders for LineaDNA from...

BNB Plus Corp. (BNBX) Appoints James Haft as Independent Board Director

BNB Plus Corp. (Nasdaq: BNBX) ('BNBX' or the 'Company'), today announced the appointment of James Haft as an Independent Director and member of the Boards Nominating Committee, effective as of...

BNB Plus Corp. (BNBX) to Present at the Digital Asset Virtual Investor Conference January 27th

BNB Plus Corp. (Nasdaq: BNBX) ('BNBX' or the 'Company'), today announced that Chief Investment Officer Patrick Horsman, CFA and Chairman of the Board Joshua Kruger will present live at the Digital...

BNB Plus Corp. is a biotechnology company, which engages in the development and commercialization of technologies to produce and detect deoxyribonucleic acid and ribonucleic acid. It operates through the following segments: Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. The Therapeutic DNA Production Services segment consists of the enzymatic manufacture of synthetic DNA for use in the production of nucleic acid-based therapeutics and the development and sale of a proprietary RNAP for use in the production of mRNA therapeutics. The MDx Testing Services segment develops clinical molecular diagnostic and genetic tests and clinical laboratory testing services. The DNA Tagging and Security Products and Services segment is involved in the detection of DNA for industrial supply chains and security services. The company was founded in 1983 and is headquartered in Stony Brook, NY.

BNB Plus Corp.

Bullish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$0.15
Prev Close	$0.1352
Open	$0.135
Dividend Yield	0.00%
50-Day Moving Average	$2.49
Beta	-1.19
Avg. Volume	125,588.50
PE Ratio	0.00

52-Week High	$7.15
52-Week Low	$0.066
Market Capitalization	$929,584.00
EPS (Annual)	-$134.23
Price to Book	0.07
Revenue Per Employee	$82,189.81

Feed

News

Sentiment

Earnings

Fundamentals

Info